Skip to Main Content

INFORMATION FOR

AHA Scientific Sessions 2022: Latest updates from Yale Cardiovascular Medicine

August 17, 2022
by Elisabeth Reitman

The 2022 American Heart Association's Scientific Sessions will highlight important new research by young investigators in the fields of electrophysiology, heart failure, hypertension, health equity, and more. Faculty members and trainees at the Yale School of Medicine and the Section of Cardiovascular Medicine will also present novel evidence-based therapies and discuss emerging technologies to advance patient care.

Non late-breaking abstracts will be available online Monday, October 31.

Early Career:

November 4

CO.EC.288. Forging Your Path - Building Careers in Cardio-Oncology

S102BC

Lauren A Baldassarre

QU.EC.98. Team Science as an Early Career Investigator: Teamwork Makes the Dream Work

S106A

Building your team locally, nationally, and internationally – the academic perspective

Rohan Khera

November 5

VA.AOS.384. Jay D. Coffman Early Career Investigator Award Competition

S106A

151 - Drug-coated Balloon And Drug-eluting Stent Safety In Patients With Femoropopliteal And Severe Chronic Kidney Disease

Jonathan Hanna, Yale Sch of Med, New Haven, CT; Kim G Smolderen, Yale Univ, New Haven, CT; Yulanka Castro-Dominguez, Univ Hosp, Cleveland, OH; Gaelle Romain, Yale Univ, New Haven, CT; Megan Lee, Jeffrey Turner, Yale Sch of Med, New Haven, CT; Carlos Mena-Hurtado, Yale Univ, New Haven, CT

EA.AOS.369. Samuel A. Levine Early Career Clinical Investigator Award Competition

S103A

169 - Racial Disparities In Transcatheter And Surgical Aortic Valve Replacement Among Medicare Beneficiaries In The United States, 2012-2019

Aakriti Gupta, Cedars-Sinai Medical Ctr, Los Angeles, CA; Makoto Mori, Yale Sch of Med, New Haven, CT; yun wang, Yale Sch of Med, New Haven, CT, New Haven, CT; Torsten Vahl, Yale Sch of Med, New Haven, CT, New Haven, CT, New York, NY; Tamim Nazif, Columbia Univ Medical Ctr, New York, NY; Oyere Kalu Onuma, Yale Univ, New Haven, CT; Celina M Yong, STANFORD UNIVERSITY, Menlo Park, CA; Rahul Sharma, Stanford Medical Ctr, Palo Alto, CA; Ajay J Kirtane, Columbia Univ Medical Ctr, New York, NY; John K Forrest, Yale Univ, Hamden, CT; Isaac George, Columbia Univ Medical Ctr, New York, NY; Susheel K Kodali, Columbia Univ; Joanna Chikwe, Cedars-Sinai, Los Angeles, CA; Arnar Geirsson, Yale Univ, New Haven, CT; Raj Makkar, Cedar Sinai Medical Ctr, Los Angeles, CA; Martin Leon, Columbia Univ Medical Ctr; Harlan M Krumholz, Yale Univ, New Haven, CT

EP.AOS.380. Elizabeth Barrett-Connor Research Award for Early Career Investigators in Training Competition

174 - Detection of Left Ventricular Systolic Dysfunction From Electrocardiographic Images

Veer Sangha, Yale Universty, New Haven, CT; Arash Aghajani Nargesi, New Haven, CT; Lovedeep Dhingra, New Haven, CT, New Haven, CT; Bobak Mortazavi, Texas AM Univ, College Station, TX; Antonio H Ribeiro, Uppsala Univ, Sweden; Evgeniya Banina, Cynthia Brandt, Lake Regional Hosp, MO; Edward J Miller, YALE UNIVERSITY SCHOOL OF MEDICINE, New Haven, CT; Antonio Ribeiro, UFMG, Belo Horizonte, Brazil; Eric Jose Velazquez, Yale Univ Sch of Med, New Haven, CT; Harlan M Krumholz, Yale Univ, New Haven, CT; Rohan Khera, Yale Sch of Med, New Haven, CT


Frontiers in Science:

November 4

EA.FIS.480. Arrhythmia Research Summit - Evaluation and Management of Syncope and Cardiac Dysautonomias: A 2022 Update

S102D

Driving restrictions in patients with reflex and unexplained syncope

Rachel J Lampert


Posters and Abstracts:

November 5

EP.MDP13. When the Sum is Greater Than the Parts: Cardiovascular Health and Its New Metric, Sleep

MP22 - Trends And Clustering In Cardiovascular Health Metrics By Race And Ethnicity Among Us Adults, 2011-2020

Yuan Lu, Yale Univ, New Haven, CT; Xumin Li, Los Angeles, CA; Yuntian Liu, Los Angeles, CA, New Haven, CT; Erica S Spatz, YALE UNIVERSITY SCHOOL MEDICINE, New Haven, CT; Jeph Herrin, FBA, Charlottesville, VA; Harlan M Krumholz, Yale Univ, New Haven, CT

PH.APS.P62. Improving Outcomes the Cardiac Intensive Care Unit: Leveraging Existing Technology and New Innovations

Zone 4

SA4199 / 4199 - Delays In Care And Outcomes In Out-of-hospital Cardiac Arrest With Shockable Rhythm

Kevin M Wheelock, Yale Sch of Med, New Haven, CT; Elliott Miller, Yale Univ, New Haven, CT; Rohan Khera, Yale Sch of Med, New Haven, CT

PR.APS.P87. Stress Testing and Sports Cardiology

Zone 3

SA3119 / 3119 - Atrial Fibrillation Worsens Sports Performance In Athletes; Greatest Improvement Seen With Ablation: A Stopafib.org Survey

Ali K Khan, Yale Univ Sch of Med, New Haven, CT; Hyon Jae Lee, Brookline, MA; Mellanie True Hills, Melissa Moss, Brenna Lara, StopAfib.org, Greenwood, TX; Raymond Baumann, Cynthia Brandt, Rachel J Lampert, Yale Univ Sch of Med, New Haven, CT

SA.APS.P61. Thoracic Aortic Disease 1

Zone 4

SA4238 / 4238 - Coronary Ectasia In Patients With Thoracic Aortic Aneurysm

Rishi Tripathi, Yale Univeristy Sch of Med, New Haven, CT; Mohammad Zafar, Yale, New Haven, CT; Bulat A Ziganshin, John A Elefteriades, YALE UNIVERSITY SCHOOL MEDICINE, New Haven, CT; Elissa Altin, Yale Univ

SA.APS.P63. Thoracic Aortic Disease 2

Zone 4

SA4245 / 4245 - Connective Tissue Disease Subtype And Pregnancy: Risk Of Lifelong Thoracic Aortic Aneurysmal Disease

Afsheen Nasir, Yale Sch of Med, Aortic Inst, New Haven, CT; Mohammad Zafar, Yale, Shelton, CT; Asanish Kalyanasundaram, Yale Aortic Inst, New Haven, CT; Alexandra Sonsino, Dimitra Papanikolaou, Yale Sch of Med, Aortic Inst, New Haven, CT; Maryam Tanweer, BEACON FALLS, CT; Yupeng Li, Rowan Univ, Glassboro, NJ; Bulat A Ziganshin, YALE UNIVERSITY SCHOOL MEDICINE, New Haven, CT; robert elder, katherine H. campbell, Yale Sch of Med, New Haven, CT; Lawrence S Cohen, YALE UNIV SCHOOL MEDICINE, New Haven, CT; John A Elefteriades, YALE UNIVERSITY SCHOOL MEDICINE, New Haven, CT; Josephine Chou, Yale Univ, New Haven, CT

PR.APS.P105. Cutting Edge Approaches to Risk Assessment and Prediction

Zone 3

SA3125 / 3125 - A Nationally Representative Evaluation Of Patients With Established Cardiovascular Disease And Cardiovascular Risk Factors Achieving Health Goals With Electronic Devices In The United States

Arya Aminorroaya, CORE, Yale Sch of Med, New Haven, CT; Lovedeep S Dhingra, Yale Sch of Med, New Haven, CT; Evangelos Oikonomou, Yale Sch of Med, New Haven, CT, New Haven, CT; Arash Aghajani Nargesi, Yale Sch of Med, New Haven, CT, New Haven, CT, New Haven, CT; Rohan Khera, Yale Sch of Med, New Haven, CT

QU.APS.P86. Acute Coronary Syndromes: Enhancing the Quality of Care and Improving Outcomes

Zone 3

SA3173 / 3173 - Outcomes Of Right Heart Catheterization In Patients With ST-Elevation Myocardial Infarction And Cardiogenic Shock: A Nationwide Analysis From The United States

Mahmoud Ismayl, Creighton Univ Sch of Med, Omaha, NE; Andrew M Goldsweig, Univ of Nebraska Med Ctr, Omaha, NE; Elissa Altin, Yale Univ Sch of Med, New Haven, CT

VA.APS.P78. Vascular Medicine From Head to Toe: Looking to a Bright Research Horizon 1

Zone 4

SA4283 / 4283 - Guideline Directed Medical Therapy After Peripheral Vascular Intervention And Association With Long-term Outcomes At An Academic Health System

Jiun-Ruey Hu, Kim G Smolderen, Jeremy A Provance, Gaelle Romain, Yale Sch of Med, New Haven, CT; Andreas Baumbach, Queen Mary Univ of London and Barts Heart Ctr, London, United Kingdom; Eric J Velazquez, Yale Sch of Med, New Haven, CT; Francine Lorusso, Yale New Haven Hosp, New Haven, CT; Keith Churchwell, Wade L Schulz, Lindsey Scierka, Carlos Mena-Hurtado, Yale Sch of Med, New Haven, CT

HT.AOS.363. From Deep Learning to Neural Networks: The Use of Artificial Intelligence to Detect Cardiovascular Disease

S104B

234 - Automated Detection Of Aortic Stenosis From Single-view 2-dimensional Echocardiography Using A Semi-supervised, Contrastive Learning Approach

Evangelos K Oikonomou, Yale Sch of Med, New Haven, CT; Gregory Holste, The Univ of Texas at Austin, Austin, TX; Bobak Mortazavi, Texas AM Univ, College Station; Zhangyang Wang, The Univ of Texas at Austin, Austin, TX; Rohan Khera, Yale Sch of Med, New Haven, CT

HY.AOS.423. Novel Insights in Hypertension Control and Management from Intervention Studies

S101A

242 - Choice Of Antihypertensive Agent In Isolated Systolic Hypertension And Isolated Diastolic Hypertension: A Secondary Analysis Of The Allhat Trial

Stephen Y Wang, Yale-New Haven Hosp, New Haven, CT; Jonathan M Hanna, New Haven, CT; Prajesh Gongal, New Haven, CT, Lebanon, NH; Oyere Onuma, Yale Univ, New Haven, CT; Michael Nanna, Yale Univ, New Haven, CT, New Haven, CT

VA.APS.P1006. Potpourri of Vascular Disease and Thrombosis

VP477 - Health Status Profiles in Patients With New or Worsening Peripheral Artery Disease Symptoms and One-Year Hospitalization Risk

Lindsey Scierka, Yale Univ, New Haven, CT; Clementine Labrosciano, Univ of Adelaide, Woodville, Australia; Brooklyn Bradley, Yale Univ, New Haven, CT; Robert Fitridge, The Univ of Adelaide, Adelaide, Australia; John Spertus, Saint Luke's Mid America Heart Inst, Kansas City, MO; Carlos Mena-Hurtado, Kim G Smolderen, Yale Univ, New Haven, CT

EP.APS.P327. EPI, Big Data and Precision Medicine

VP168 - Comorbid Obesity in Symptomatic Peripheral Artery Disease: A Modifiable Factor Associated With Health Status

Lindsey Scierka, Yale Univ, New Haven, CT; poghni A peri-Okonny, Saint Luke's Mid America Heart Inst, kansas city, MO; Carlos Mena-Hurtado, Yale Univ, New Haven, CT; Kensey Gosch, Saint Luke's Hosp, Kansas City, MO; John Spertus, Saint Luke's Mid America Heart Inst, Kansas City, MO; Robert Fitridge, The Univ of Adelaide, Adelaide, Australia; Patrick W Vriens, ST ELISABETH ZIEKENHUIS TILBURG, Tilburg; Sabita Soedamah-Muthu, Tilburg Univ, Tilburg; Kim G Smolderen, Yale Univ, New Haven, CT

QU.APS.P296. Cardiovascular Outcomes Research Leveraging Science to Improve Care

VP424 - Integrating Mental Health Screening Into A Health System For Measurement-based Care Of Patients With Peripheral Artery Disease

Lindsey Scierka, Carlos Mena-Hurtado, Gaelle Romain, Jeremy A Provance, Brooklyn Bradley, Shannon Lynch, Alexandria Bascombe, Yale Univ, New Haven, CT; Waleed Tariq Siddiqui, Yale Univ; Mufti Rahman, Yale Univ, New Haven, CT; Pragati Bogra, Yale Univ; Evy van Roij, Sameer Nagpal, Yale Univ, New Haven, CT; Francine Lorusso, Eric J Velazquez, Yale Univ Sch of Med, New Haven, CT; Keith B Churchwell, YALE NEW HAVEN HOSPITAL, New Haven, CT; Kim G Smolderen, Yale Univ, New Haven, CT

November 6

CM.APS.P203. The Forest vs. the Trees: Caring for Populations of Patients with Diabetes

Zone 3

SU3026 / 3026 - Access To Specialty Cardiovascular Care And Uptake Of Cardioprotective Anti-hyperglycemic Agents Among Adults With Type 2 Diabetes: A Cohort Study

Arash Aghajani Nargesi, New Haven, CT; Callahan Clark, Minneapolis, MN; Mengni Liu, Minneapolis, MN, Elmhurst, NY; Abraham Reddy, Minneapolis, MN, Elmhurst, NY, Minneapolis, MN; Sam Amodeo, Minneapolis, MN, Elmhurst, NY, Minneapolis, MN, Minneapolis, MN; Rohan Khera, Yale Sch of Med, New Haven, CT

HF.APS.P123. Novel Diagnostic Methods and Predictors for Cardiovascular Disease

Zone 2

SU2139 / 2139 - Prompting Providers With Electronic Alerts Improves Long-term Uptake Of Guideline-directed Medical Therapy For Heart Failure

Lama Ghazi, Yu Yamamoto, Yale Univ, New Haven, CT; Ralph J Riello III, Yale Sch of Med, New Haven, CT; Melissa Martin, Yale Sch of Med, New Haven, CT, New Haven, CT; Kyle O'Connor, Yale Sch of Med, New Haven, CT, New Haven, CT, New Haven, CT; Joanna Huang, Yale Sch of Med, New Haven, CT, New Haven, CT, New Haven, CT, Princeton, NJ; Tope Olufade, AstraZeneca, Wilmington, DE; Jim McDermott, Astra Zeneca, Wilmington, DE; Kristine Anne Sobolewski, Karthik Linganathan, AstraZeneca, MA; Michael Fuery, New Haven, CT; Silvio E Inzucchi, YALE UNIVERSITY SCHOOL OF MED, Stratford, CT; F. Perry Wilson, YALE UNIVERSITY SCHOOL OF MED, Stratford, CT, New Haven, CT; Nihar R Desai, Yale Sch of Med, New Haven, CT; Tariq Ahmad, Yale Medical Ctr, Guilford, CT

HF.APS.P124. Drugs, Drugs and More Drugs in Heart Failure: Impact on Outcomes

Zone 2

SU2151 / 2151 - Defining Phenotypic Representativeness Of The TOPCAT Trial To A Real-world Electronic Health Record Using Multidimensional Phenomaps

Phyllis Thangaraj, Yale Univ, New Haven, CT; Evangelos Oikonomou, New Haven, CT; Rahul Jayaram, Yale Univ, New Haven, CT; Arash Aghajani Nargesi, Yale Univ, New Haven, CT, New Haven, CT; Marc Suchard, Yale Univ, New Haven, CT, New Haven, CT, Los Angeles, CA; Rohan Khera, Yale Sch of Med, New Haven, CT

CH.APS.P175. Single Ventricle - Pediatric Cardiology 2

Zone 4

SU4013 / 4013 - Clinical Characteristics And Predictors Of The “Good Fontan”: A Multi-institutional Study

Robert W. Elder, Yale Sch of Med, New Haven, CT; Anne M Valente, BOSTON CHILDRENS HOSPITAL, Boston, MA; Brooke Davey, Connecticut Children's, Hartford, CT; Fred Wu, Boston Children s Hosp, Boston, MA; Nancy A Drucker, Univ of Vermont Medical Cente, Burlington, VT; Kristin Lombardi, Warren Alpert Medical Sch at Brown Univ, Providence, RI; Seohyuk Lee, Yale Sch of Med, New Haven, CT; Nicole St. Clair, Boston Children's Hosp, Boston, MA; Olga H Toro-salazar, CONNECTICUT CHILDRENS MEDICAL CTR, Hartford, CT; Rahul Rathod, BOSTON CHILDRENS HOSPITAL, Boston, MA

DD.APS.P121. Drug Discovery for Cardiovascular Disease

Zone 1

SU1073 / 1073 - Renalase Peptide Agonist Therapy Normalizes The Cardiac Response To Pressure Overload In Chronic Kidney Disease

Govind Krishna Kumar Nair, Jiasheng Zhang, Xiaojia Guo, nicole guerrera, Xiaohong Wu, Xiaoyue Hu, Fred S. Gorelick, Robert Safirstein, Frank J Giordano, Lawrence H Young, Gary V. Desir, Yale Univ Sch of Med, New Haven, CT

EP.APS.P204. Epidemiology of Peripheral Artery Disease

Zone 3

SU3072 / 3072 - The Association Between Neighborhood Distress And Outcomes Following Peripheral Vascular Intervention

Eric Strand, Kim G Smolderen, Gaelle Romain, Yale Univ, New Haven, CT; Matthew Burg, Yale Sch of Med, West Haven, CT; Kamil Faridi, Yale Sch of Med, New Haven, CT; Keith B Churchwell, YALE NEW HAVEN HOSPITAL, New Haven, CT; Carlos Mena-Hurtado, Yale Univ, New Haven, CT

SU3073 / 3073 - In-Hospital Outcomes In Patients With Peripheral Artery Disease Hospitalized For Acute Myocardial Infarction: From The NCDR Chest Pain Mi Registry

Kamil F Faridi, Yale Sch of Med, New Haven, CT; Shuang Li, Tracy Y Wang, DCRI, Durham, NC; Carlos Mena-Hurtado, Kim G Smolderen, Yale Univ, New Haven, CT; Jennifer A Rymer, Duke, Durham, NC; Jeptha P Curtis, YALE UNIVERSITY, New Haven, CT; Eric A Secemsky, BIDMC, Boston, MA

EP.APS.P206. Rigor and Reason in Understanding Patterns of Cardiovascular Risk

Zone 3

SU3076 / 3076 - An Adaptive Strategy Of Predictive Enrichment To Increase Efficiency Of Randomized Clinical Trials Using Machine Learning: A Simulation Of The IRIS Trial

Evangelos K Oikonomou, Yale Sch of Med, New Haven, CT; Marc A Suchard, Los Angeles, CA; Walter N Kernan Jr., YALE UNIVERSITY, New Haven, CT; Lawrence H Young, YALE UNIV SCH MED, New Haven, CT; Silvio E Inzucchi, YALE UNIVERSITY SCHOOL OF MED, Stratford, CT; Rohan Khera, Yale Sch of Med, New Haven, CT

SU3088 / 3088 - Do Beta-blockers Confer Cardiovascular Protection In Patients With Stable Coronary Artery Disease In The Contemporary Era?

Lucas C Godoy, Univ of Toronto, Toronto, ON, Canada; Michael E Farkouh, Peter Munk Cardiac Ctr, Toronto, ON, Canada; Peter Austin, ICES, Toronto, ON, Canada; Baiju Shah, Sunnybrook Health Sciences Ctr, Toronto, ON, Canada; Feng Qiu, ICES, Toronto, ON, Canada; Cynthia Jackevicius, Western Univ, Pomona, CA; Harindra C Wijeysundera, Sunnybrook Health Sciences Ctr, Toronto, ON, Canada; Harlan M Krumholz, Yale Univ, New Haven, CT; Dennis T Ko, Sunnybrook Health Sciences Ctr, Toronto, ON, Canada

QU.APS.P188. Learning Health Systems: the Supporting Science

Zone 3

SU3172 / 3172 - Use Of Electronic Health Records To Develop An Actionable Taxonomy Of Patients With Persistent Hypertension

Yuan Lu, Cindy Hu, Hazar Khidir, Yale Univ, New Haven, CT; Cesar Caraballo, Yale Sch of Med, New Haven, CT; Shiwani Mahajan, Yale Univ Sch of Med, New Haven, CT; Erica S Spatz, YALE UNIVERSITY SCHOOL MEDICINE, New Haven, CT; Leslie Curry, YALE, Killingworth, CT; Harlan M Krumholz, Yale Univ, New Haven, CT

VA.APS.P178. Vascular Medicine From Head to Toe: Looking to a Bright Research Horizon 2

Zone 4

SU4234 / 4234 - The Impact Of Ejection Fraction On Major Adverse Limb Events After Lower Extremity Revascularization

Yasser Jamil, Yale Sch Of Med, New Haven, CT; Joshua Huttler, Yale Univ Sch Of Med, CT; Dana Alameddine, Haoran Zhuo, Yale Univ Sch Of Med, New Haven, CT; Carlos Mena-Hurtado, Yale Univ, New Haven, CT; Eric Jose Velazquez, Yale Univ Sch of Med, New Haven, CT; Raul J Guzman, Yale New Haven Hosp, New Haven, CT; Cassius Iyad I Ochoa Chaar, Yale Sch of Med, New Haven, CT

IN.APS.P325 - TAVR in Special Populations

Zone 2

SU2365 / 2365 - Impact of Dementia on Inpatient Outcomes and Readmission Risks After Transcatheter Aortic Valve Replacement

Dae Yong Park, Cook County Health, Chicago, IL; Muhammad Khawar Sana, Chicago, IL; Sami Shoura, Hasan Hammo, Cook County Health, Chicago, IL; Jiun-Ruey Hu, New Haven, CT; Angela Lowenstern, Vanderbilt Univ, Nashville, TN; Yousif Ahmad, Vanderbilt Univ, Nashville, TN, New Haven, CT; Michael Nanna, Vanderbilt Univ, Nashville, TN, New Haven, CT, New Haven, CT

QU.MDP32 - Improving Cardiovascular Health: Prediction, Processes and Programs

MP112 - Development of a 30-Day Health Status Prediction Model for High-Risk Transfemoral Carotid Artery Stenting Using a Simple Machine Learning Algorithm

Kristie M Harris, Gaelle Romain, Jacob Cleman, Carlos Mena-Hurtado, Kim G Smolderen, Yale Sch of Med, New Haven, CT

November 7

NE.AOS.428. Inflammation and Cardiovascular Complications in Patients With Kidney Disease

S101B

390 - Prevalence And Characteristics Of Systemic Inflammation In Adults With Atherosclerotic Cardiovascular Disease And Chronic Kidney Disease: Results From The National Health And Nutrition Examination Survey

Michael Nanna, Yale Univ, New Haven, CT; Lance Sloan, Texas Inst for Kidney and Endocrine Disorders, Lufkin, TX; Mads Faurby, Lise Lotte N Husemoen, Gamze Tombak, Novo Nordisk A/S, Søborg, Denmark; Deepak Yerragolam, Novo Nordisk Service Ctr Pvt Ltd, Bangalore, India; Naveed Sattar, Univ of Glasgow, Glasgow, United Kingdom

MP.AOS.472. Inflammatory Mechanisms of Cardiac Disease

S102A

405 - AT1R Autoantibody Levels Are Elevated In Patients Who Required Immunosuppression Escalation In Immune Checkpoint Inhibitor Mediated Myocarditis

Narjes Akhlaghi, Yale, New Haven, CT; Miles Shen, New Haven, CT; Laurine Bow, Maureen Miller, Yale, New Haven, CT; John Hwa, YALE SCHOOL MEDICINE, New Haven, CT; Stephanie Halene, Yale, New Haven, CT; Lauren A Baldassarre, Yale Univ, New Haven, CT; Jennifer M Kwan, Yale, New Haven, CT

VA.AOS.477. Peripheral Artery Disease - A Matter of Life and Limb

S106B

419 - A Call To Action For Mental Health Needs Amongst Patients Diagnosed With Critical Limb Ischemia: Insights From The Scope-cli Registry

Kim G Smolderen, Yale Univ, New Haven, CT; Mehdi H Shishehbor, Univ Hosp of Cleveland, Cleveland, OH; Olamide Alabi, Emory Univ, Atlanta, GA; Robert Fitridge, The Univ of Adelaide, Adelaide, Australia; Jeremy A Provance, Yale Sch of Med, New Haven, CT; Trissa Babrowski, UNIVERSITY OF CHICAGO, Chicago, IL; Gaelle Romain, Yale Univ, New Haven, CT; PETER A SOUKAS, MIRIAM CARDIOLOGY, PROVIDENCE, RI; Matthew C Bunte, MIRIAM CARDIOLOGY, PROVIDENCE, RI, Leawood, KS; Lindsey Scierka, Yale Univ, New Haven, CT; Evy van Roij, Yale Univ, New Haven, CT, New Haven, CT; Carlos Mena-Hurtado, Yale Univ, New Haven, CT; On Behalf of the SCOPE-CLI Consortium

EA.RFO34. New insights into Atrial Fibrillation Ablation

Zone 4

577 - Regional Variation In Atrial Fibrillation Ablation Care For Medicare Beneficiaries Across The United States

Jonathan Hanna, Yale Sch of Med, New Haven, CT; James V Freeman, YALE UNIV SCHOOL MEDICINE, New Haven, CT; James Hummel, Yale Sch of Med, New Haven, CT; Jeptha P Curtis, YALE UNIVERSITY, New Haven, CT; Zhenqiu Lin, YALE UNIVERSITY, New Haven, CT, Cheshire, CT; Joseph Akar, Yale Univ, New Haven, CT; Rohan Khera, Yale Sch of Med, New Haven, CT

580 - Characteristics And In-hospital Outcomes Of Patients Undergoing Pulmonary Vein Isolation With And Without Adjunctive Lesions: Insights From The Ncdr Afib Ablation Registry

Douglas J Darden, La Jolla, CA; Omar M Aldaas, Corona, CA; Chengan Du, Yale Univ, New Haven, CT; Gregory K Feld, Univ of California San Diego, La Jolla, CA; Krishna Pothineni, Univ of California San Diego, La Jolla, CA, KS; Rakesh Gopinathannair, Dhanunjaya R Lakkireddy, Kansas City Heart Rhythm Inst, Overland Park, KS; Jeptha P Curtis, YALE UNIVERSITY, New Haven, CT; James V Freeman, YALE UNIV SCHOOL MEDICINE, New Haven, CT; Joseph Akar, Yale Univ, New Haven, CT; Jonathan C Hsu, UNIVERSITY OF CALIFORNIA SAN DIEGO, La Jolla, CA

EP.APS.P290. Next Steps in Hypertension Management

Zone 3

MO3008 / 3008 - Mobile Health Interventions And Remote Blood Pressure Monitoring In Underserved Populations: A Systematic Review And Meta-analysis

Miriam Katz, New York Medical Coll, NY; Reed Mszar, Georgetown Univ, DC; Alyssa A Grimshaw, Yale Univ, West Haven, CT; Erica S Spatz, YALE UNIVERSITY SCHOOL MEDICINE, New Haven, CT

HF.APS.P314. My Achy Breaky Heart: Takotsubos, Hypertropic Cardiomyopathy and Valvular Disease

Zone 2

MO2131 / 2131 - Incidence And Risk Factors For Takutsubo Syndrome After Inpatient Chemotherapy : Nationwide Readmissions Database Analysis

Jay Parekh, Sun-Joo A Jang, Aslihan Yerlikaya, Yale New Haven Health, Bridgeport, CT; Eejung Kim, Yale New Haven Hosp, New Haven, CT; Jong Chul Park, Harvard Medical Sch, Boston, MA; Illhwan Yeo, Weill Cornell Medical Coll, NY; Avirup Guha, Medical Coll of Georgia, Augusta, GA; Tariq Ahmad, Yale Medical Ctr, Guilford, CT

IM.APS.P245. The Nuclear Cardiology 3I's: Ischemia, Inflammation and Infiltrative disease

Zone 2

MO2186 / 2186 - Obstructive Sleep Apnea Severity And Abnormal Right Ventricular Flow Reserve In Adult Osa Patients Who Received Rubidium-82 Cardiac Pet Perfusion Imaging.

Ehimen C Aneni, Yale Univ, New Haven, CT; Edward J Miller, YALE UNIVERSITY SCHOOL OF MEDICINE, New Haven, CT; Gul Jana Saeed, YALE UNIVERSITY SCHOOL OF MEDICINE, New Haven, CT, Karachi, Pakistan; Robert deKemp II, uOttawa Heart Inst, Ottawa, ON, Canada; RAN KLEIN, Univ of Ottawa, Ottawa, ON, Canada; Rob S Beanlands, UNIVERSITY OTTAWA HEART INSTITUTE, Ottawa, ON, Canada; Henry KLAR Yaggi IV, Yale Univeristy Sch of Med, New Haven, CT; Albert J Sinusas, YALE UNIVERSITY SCHOOL MEDICINE, New Haven, CT; Stephanie Thorn, YALE UNIVERSITY, New Haven, CT

PD.APS.P235. Advances in Curricular and Educational Programs in Cardiology

Zone 2

MO2295 / 2295 - Shared Curriculum Delivery Gaps Among Advanced Heart Failure And Transplant Cardiology Fellowship Programs

Michael H Beasley, Donna Windish, Yale Sch of Med, New Haven, CT

DD.MDP42. Pharmacological Research in Cardiac Electrophysiology

Moderated Posters 2, Science and Technology Hall

MP229 - Optical Mapping In Atrial Engineered Heart Tissues Reveals Proarrhythmic Potential Of The Anti-AF Agent Vernakalant

Ilhan Gokhan, Afia Sarpong Frimpong, Marine Cacheux, Stuart G Campbell, Yale Univ, New Haven, CT; Fadi G Akar, YALE UNIVERSITY, New Haven, CT

EA.APS.P278. Broadening Our Understanding of Anticoagulation in the Setting of Atrial Fibrillation

Zone 4

MO4086 / 4086 - Association Between Oral Anticoagulant Type And Hospital Readmission Rates Following Myocardial Infarction With Percutaneous Coronary Intervention In Patients With Nonvalvular Atrial Fibrillation

Nihar Desai, Yale Sch of Med, New Haven, CT; Afraim Botros, Bristol Myers Squibb, Lawrenceville, NJ; Ankita Panda, Mu Sigma, Northbrook, IL; Qian Xia, Bristol Myers Squibb, Princeton Pike, NJ; Keith Huff, Bristol Myers Squibb, Lawrenceville, NJ

GR.APS.P300. Race, Ethnicity and Cardiovascular Health

Zone 3

MO3041 / 3041 - Trends In Prevalence And Treatment Of Metabolic Syndrome And Individual Components By Race/ethnicity, 1999-2020

Yuan Lu, Xumin Li, Yale Univ, New Haven, CT; Yuntian Liu, New Haven, CT; Cesar Caraballo, Yale Sch of Med, New Haven, CT; Shiwani Mahajan, Yale Univ Sch of Med, New Haven, CT; Daisy Massey, Yale Univ Sch of Med, New Haven, CT, New Haven, CT; Erica S Spatz, YALE UNIVERSITY SCHOOL MEDICINE, New Haven, CT; Jeph Herrin, FBA, Charlottesville, VA; Harlan M Krumholz, Yale Univ, New Haven, CT

IN.APS.P242. The Latest and the Greatest Research on Left Atrial Appendage Procedures

Zone 2

MO2279 / 2279 - Safety And Effectiveness Of Pre-procedure Imaging For Percutaneous Left Atrial Appendage Occlusion: Insights From The National Cardiovascular Data Registry (NCDR) LAAO Registry

John-Ross D Clarke, Beth Israel Deaconess Medical Ctr, Boston, MA; Angela Y Higgins, Maine Health, Scarborough, ME; Yongfei Wang, YALE UNIVERSITY SCHOOL OF MEDICINE, Cheshire, CT; Kamil Faridi, Yale Sch of Med, New Haven, CT; Jeptha P Curtis, YALE UNIVERSITY, New Haven, CT; James V Freeman, YALE UNIV SCHOOL MEDICINE, New Haven, CT; Daniel Friedman, Duke Univ, Durham, NC

VA.APS.P276. Every Step Counts: Insights from the Latest Research in PAD

Zone 4

MO4228 / 4228 - Development And Validation Of The Peripheral Artery Questionnaire For Critical Limb Ischemia-(paq-cli) Instrument

Kim G Smolderen, Yale Univ, New Haven, CT; John Spertus, Saint Luke's Mid America Heart Inst, Kansas City, MO; Gaelle Romain, Yale Univ, New Haven, CT; Christina Pacheco, Kansas Univ, Kansas City, KS; Kate Scott, Saint Luke's Mid America Heart Inst, MO; Nancy Stone, Saint Luke's Mid America Heart Inst, MO, Kansas City, MO; Lindsey Scierka, Yale Univ, Cheshire, CT; Christine Fuss, Mid America Heart Inst, Kansas City, MO; Evy van Roij, Carlos Mena-Hurtado, Yale Univ, New Haven, CT

HT.AOS.434. Wearable Devices to Improve Cardiovascular Disease Outcomes

S104B

440 - Use Of Wearable Devices By Patients With And At-risk For Cardiovascular Disease In The United States: A Nationally Representative Study

Lovedeep S Dhingra, Yale Sch of Med, New Haven, CT; Arya Aminorroaya, CORE, Yale Sch of Med, New Haven, CT; Evangelos Oikonomou, CORE, Yale Sch of Med, New Haven, CT, New Haven, CT; Arash Aghajani Nargesi, CORE, Yale Sch of Med, New Haven, CT, New Haven, CT, New Haven, CT; Rohan Khera, Yale Sch of Med, New Haven, CT



Cardiovascular Seminar:

November 4

NE.CVS.508.

Kidney function outcomes with acute mechanical circulatory support

S106B

Carlos Davila

November 5

QU.CVS.229. Shared Decision-Making: Partnering to Improve Cardiovascular Health

S102A

Erica S Spatz


LF.CVS.352. Enhancing Cardiovascular Disease Prevention Through Promoting Equity in Lifestyle

N230B

Keith B Churchwell; Norrisa Haynes


QU.CVS.399. Making the Learning Health System a Reality

N139

Erica S Spatz


IM.CVS.270. Confronting the Epidemic of Amputations in Underserved Diabetic Populations

N427BC

Can Early Diagnosis and Treatment Make a Difference?

Carlos Mena-Hurtado

November 6

HF.CVS.217. Health Disparities Across The Heart Failure Disease Spectrum: A Way Forward?

S105D

How Physicians Can Influence Health Policy to Promote Equity in Heart Failure

Harlan M Krumholz

IM.CVS.272. Cardiovascular Nano & Molecular Medicine: Delivering on the Promise

S102BC

Multi-modality Molecular Imaging and Smart Nanoprobes

Albert J Sinusas

The session highlights molecular imaging technologies and multimodality uses for detecting cardiovascular disease.

CO.CVS.289. Molecular Targets in Oncology Driving Cardiovascular Discovery and Therapy

N138

Jennifer M Kwan

This session focuses on molecular mechanisms and treatments for cancer.

AT.CVS.271. Vascular Smooth Muscle Cell Phenotypic Modulation in Vascular Disease and Aging

S103A

Transcriptional regulation of smooth muscle cell fate in development and disease

Kathleen Martin

This session focuses on vascular smooth muscle cell phenotypic modulation.



On Demand Abstract Poster Session:

Session AC.APS.P303 Novel Insights Into the Management of Stable Coronary Artery Disease

Coronary Artery Bypass Graft Surgery Shows Improved Restricted Mean Survival Time and Time Lost Compared to Medical Therapy in Patients With Left Ventricular Dysfunction: From the STICH Trial

Samuel W Reinhardt, Haocheng Huang, Helen Parise, Yale Sch of Med, New Haven, CT; Tariq Ahmad, Yale Sch of Med, CT; Eric J Velazquez, Kamil F Faridi, Yale Sch of Med, New Haven, CT

Feature Sessions:

November 5 The Main Event: Changing Clinical Practice

Session LBS.01.Comparative Effectiveness of Torsemide versus Furosemide in Heart Failure: Primary Results of the TRANSFORM-HF Trial

Robert J Mentz, DUKE UNIVERSITY HOSPITAL, Durham, NC; Kevin Anstrom, Univ of North Carolina, Chapel Hill, Chapel Hill, NC; Eric L Eisenstein, Duke Clinical Reseach Inst, Durham, NC; Shelly Sapp, DCRI, Durham, NC; Stephen J Greene, Duke Univ Medical Ctr, Durham, NC; Shelby Morgan, Duke Clinical Res Inst, Durham, NC; VANDANA SACHDEV, NATIONAL INSTITUTES OF HEALTH, Bethesda, MD; Fassil Ketema, Dong-Yun Kim, NHLBI, Bethesda, MD; Patrice Desvigne-Nickens, NHLBI, NIH, Bethesda, MD; Bertram Pitt, Univ of Michigan Sch of me, Ann Arbor, MI; Eric J Velazquez, Yale Univ Sch of Med, New Haven, CT

This session includes trial results that challenge current clinical practices in treating heart failure.

November 6 Implementing Machine Learning for Precision Care: Crossing the Bridge to Reality

Session EP.ME.28: Outcome-Driven Augmented Intelligence in Healthcare

Rohan Khera

This session identifies applications of machine learning and data science to broad domains of cardiovascular care.

Submitted by Elisabeth Reitman on August 17, 2022